Navigation Links
Initiation of Coverage Informational Review Issued by Scimitar Equity Research
Date:12/17/2007

BOSTON, Dec. 17 /PRNewswire/ -- Scimitar Equity Research, Inc. issues a review on Nventa Biopharmaceuticals Corporation (TSX: NVN) entitled: "A Very Promising Therapeutic and Vaccine Candidate for the Treatment of Diseases Caused by the Human Papillomavirus (HPV)." The analyst research is available on Scimitar's website: http://www.scimitarequity.com.

About Nventa Corporation:

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Exchange under the symbol NVN. For more information about Nventa, please visit http://www.nventacorp.com.

About HspE7, Nventa's Lead Product Candidate:

HspE7 is a novel therapeutic vaccine candidate for the treatment of diseases caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. HspE7 is derived from Nventa's proprietary CoVal(TM) fusion platform, which uses recombinant DNA technology to covalently fuse stress proteins to target antigens, thereby stimulating cellular immune system responses. Heat shock proteins (Hsps), also known as stress proteins, are naturally present in the human body and play important roles in the immune system, including transporting substances within cells and activating cells of the immune system.

Scimitar Equity Research, Inc. provides equity research of emerging healthcare companies for the institutional and investment communities. We certify that all the views expressed in this review, accurately reflect our personal views about NVN.TO (TSX) and its or their securities. No part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views contained in this review and we will not have any inve
'/>"/>

SOURCE Scimitar Equity Research, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
4. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
5. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
8. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
9. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
10. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation
11. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... NEW YORK, Dec. 1 WebMD ...of health information, today announced the honoree...th annual WebMD Health Heroes honor Americans with...severance, who lead an effort to help others achie...ewscom.com/cgi-bin/prnh/20091201/NY18114 ) ,, ...
(Date:12/1/2009)..., MORRISVILLE, N.C., Dec. 1 nConta...vestigation of devices for minimally-invasive trea...itiation of a feasibility clinical trial designed ...surgical and catheter procedure, the convergent pr...al atrial fibrillation (AF). This prospective, fe...
(Date:12/1/2009)..., CHICAGO, Dec. 1 At this year,s ...h America (RSNA), Royal Philips Electronics ( PHG,...space, a set of solutions that provides radiologis...ges at one workspot to help drive quality and effi... Philips will also highlight new capabilities for ...
Breaking Medicine Technology:WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4SIRO Clinpharm Collaborates with Mediscis Broadens Early Phase Drug Development Expertise 6344 1SIRO Clinpharm Collaborates with Mediscis Broadens Early Phase Drug Development Expertise 6344 2Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 1Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 2Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 3Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 4Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 5Highlights of NHLBI supported research presented at American Heart Associations Scientific Sessions 61539 1Highlights of NHLBI supported research presented at American Heart Associations Scientific Sessions 61539 2Highlights of NHLBI supported research presented at American Heart Associations Scientific Sessions 61539 3Highlights of NHLBI supported research presented at American Heart Associations Scientific Sessions 61539 4Highlights of NHLBI supported research presented at American Heart Associations Scientific Sessions 61539 5Highlights of NHLBI supported research presented at American Heart Associations Scientific Sessions 61539 6
... today launched a web-based stroke education and a...ional football player who suffered a stroke in Feb... his career. The unique online educational program... on the AGA Medical website that describe Tedy,s f...nd prevention champion. , , "I hope that by shari...
...d Non-invasive Test Procedure , , MINEOLA, N.Y., ...nt step in the development of an improved first an...screening test to detect Down syndrome and other g...nary study results at the 29th annual Society for ...at indicate a potential breakthrough in testing qu...
Other Medicine Technology:AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi 2AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi 3Breakthrough in Prenatal Screening for Down Syndrome 2
(Date:12/1/2009)...ec. 1 The Kerlan Jobe O... Angeles, has agreed to pay the United States $3 m...gal kickbacks from HealthSouth Corporation, the Ju...ettlement resolves allegations that HealthSouth pa...ption grants, donations to the Kerlan Jobe Foundat...
(Date:12/1/2009)...y., Dec. 1 A scientist ...ce pain -- and ways we can control and relieve it ...meyer Award for Psychology. ,, Ronald Melzack, ... in Montreal, was selected for the award from amon...e point of injury but instead in their brain throu...
(Date:12/1/2009)...ry preterm births more likely, British study finds... Pregnant women who are poor are more likely to de..., even though both groups typically receive equal ...ty of Leicester research team said their findings ...between economic status and preterm birth. , Fo...
(Date:12/1/2009)...uggests that criteria based on computed tomography... liver metastases after chemotherapy with the drug...rall survival, according to a study in the Decembe...mab to cytotoxic (toxic to cells) chemotherapy is ... stage IV colorectal cancer and higher pathologic ...
(Date:12/1/2009)... CAEAR Foundation Changes Name to HealthHIV , ...e CAEAR Foundation, one of the largest national HI...o HealthHIV and launching a new website. The annou... of a campaign to promote the organization’s... , , , ,“HealthHIV clearly, quickly and eas...
Breaking Medicine News(10 mins):Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Scientist Who Helps Explain Pain Wins Grawemeyer Award 2Health News:More Preemies Born Among the Poor 2Health News:Criteria based on CT imaging after chemotherapy may help predict survival 2Health News:National HIV Non-Profit Announces New Name 2
...pture Emerges as Preferred Technology for Revenue ..., market leader for charge capture technologies, t...icians (UMP), a premier multi-specialty physician ...ependent not-for-profit organization with more tha...
...reast surgery products, provides insights and advi... one for jogging or other athletic activities - is...n who have had breast surgery - whether for cancer...://www.newscom.com/cgi-bin/prnh/20081016/NYFNSB01L...
...l Capital Management, Inc. (OTC Bulletin Board: UC...ompany that provides management and strategic grow...ed to announce that one of its holdings, iVolution...rk. , , The acquisition supports iVolution,s cons...
...logy Volunteer Ministers Goodwill Tour is target...ion near Samoa in the South Pacific. , ... Scientology Volunteer Ministers Goodwill Tour i... of Tongatapu, Mathew Andrews, the leader of the S...
...ene Solutions has issued a simple warning to minim... caused by the ,sneeze effect, of flushing toilets...ay 13, 2009 -- Did you know that flushing toilets ... risking the health and safety of your workforce?,...
...n College of Medical Genetics (ACMG) has joined th... of American Pathologists, and the American Societ...charging that patents on the human genes associate... challenges patents on the BRCA1 and BRCA2 genes, ...
Other Medicine News:Health News:University of Minnesota Physicians Chooses MedAptus Following Comprehensive Vendor Review 2Health News:University of Minnesota Physicians Chooses MedAptus Following Comprehensive Vendor Review 3Health News:Five Steps for Purchasing a Sports Bra After Breast Surgery 2Health News:Five Steps for Purchasing a Sports Bra After Breast Surgery 3Health News:iVolution Medical Systems Acquires Continental Collection Services 2Health News:Scientology Volunteer Ministers Target Drug and Alcohol Abuse in the South Pacific 2Health News:Pink Hygiene Issue Toilet Sneeze Warning for Workplaces 2Health News:ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics 2Health News:ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics 3
...ermal cycler can do for your laboratory. It featur...ace, and best of all, direct upgradability to real... will raise your expectations of what a thermal cy...er Features:, , Graphical representation of...
...compact thermal cycler. In addition to its speed a...sonal offers first-rate operational flexibility. I...modate 25 x 0.2 ml tubes, 16 x 0.5 ml tubes, or mi...ycler and the Mastercycler gradient, the Mastercyc...
RoboCycler® RS232 Option
... filter wheels with your choice of five (5) filter...n I (492nm-516nm), HEX/JOE/VIC (535nm-555nm), ROX/... (545-568). The system includes notebook computer,...software, User's Manual, Introduction to QPCR Guid...
Medicine Products: